Nonalcoholic fatty liver disease: Pathogenesis and the role of antioxidants

Nutrition Reviews

Volumn 60, Issue 9, 2002, Pages 289-293

  Mehta, Kapil ^a   Van Thiel, David H ^a   Shah, Nikunj ^a   Mobarhan, Sohrab ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Progressive liver fibrosis; Steatohepatitis

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMIODARONE; ANTIOXIDANT; BETAINE; CALCIUM CHANNEL BLOCKING AGENT; CHLOROQUINE; CORTICOSTEROID; GEMFIBROZIL; METFORMIN; METHOTREXATE; PERHEXILINE MALEATE; REACTIVE OXYGEN METABOLITE; TAMOXIFEN; URSODEOXYCHOLIC ACID;

ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DRUG INDUCED DISEASE; FATTY LIVER; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; RISK FACTOR; STEATOSIS; UNITED STATES;

ANTIOXIDANTS; FATTY LIVER; HUMANS;

EID: 0036718446     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/002966402320387224     Document Type: Article

References (19)

1. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
2. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
3. Nonalcoholic fatty liver disease
4. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
5. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
6. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
7. Drugs and steatohepatitis
8. Mitochondria in steatohepatitis
9. Peroxisomal beta-oxidation and steatohepatitis
10. Obesity and female gender increase breath ethanol concentration: Potential implications for the pathogenesis of nonalcoholic steatohepatitis
11. Effect of weight reduction on hepatic abnormalities in overweight patients
12. Persistent hyperaminotransferasemia resolving after weight reduction in obese children
13. Treatment of nonalcoholic fatty liver: Present and emerging therapies
14. Effect of ursodeoxycholic acid plus diet in patients with non-alcoholic steatohepatitis: Results of a prospective clinical trial
15. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study
16. Treatment of nonalcoholic steatohepatitis with N-acetylcysteine
17. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
18. Metformin in non-alcoholic steatohepatitis
19. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis